FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617007913> ?p ?o ?g. }

• W2617007913 endingPage "561" @default.
• W2617007913 startingPage "549" @default.
• W2617007913 abstract "For three decades, the treatment of small-cell lung cancer (SCLC) has remained essentially unchanged, and patient outcomes remain dismal. In the past 5 years, however, advances in our understanding of the disease, at the molecular level, have resulted in the development of new therapeutic strategies, encompassing immunotherapies and novel molecularly targeted agents. Herein, authors review the breakthroughs that hold the promise to improve SCLC outcomes. Small-cell lung cancer (SCLC) is an aggressive malignancy associated with a poor prognosis. First-line treatment has remained unchanged for decades, and a paucity of effective treatment options exists for recurrent disease. Nonetheless, advances in our understanding of SCLC biology have led to the development of novel experimental therapies. Poly [ADP-ribose] polymerase (PARP) inhibitors have shown promise in preclinical models, and are under clinical investigation in combination with cytotoxic therapies and inhibitors of cell-cycle checkpoints.Preclinical data indicate that targeting of histone-lysine N-methyltransferase EZH2, a regulator of chromatin remodelling implicated in acquired therapeutic resistance, might augment and prolong chemotherapy responses. High expression of the inhibitory Notch ligand Delta-like protein 3 (DLL3) in most SCLCs has been linked to expression of Achaete-scute homologue 1 (ASCL1; also known as ASH-1), a key transcription factor driving SCLC oncogenesis; encouraging preclinical and clinical activity has been demonstrated for an anti-DLL3-antibody–drug conjugate. The immune microenvironment of SCLC seems to be distinct from that of other solid tumours, with few tumour-infiltrating lymphocytes and low levels of the immune-checkpoint protein programmed cell death 1 ligand 1 (PD-L1). Nonetheless, immunotherapy with immune-checkpoint inhibitors holds promise for patients with this disease, independent of PD-L1 status. Herein, we review the progress made in uncovering aspects of the biology of SCLC and its microenvironment that are defining new therapeutic strategies and offering renewed hope for patients." @default.
• W2617007913 created "2017-06-05" @default.
• W2617007913 creator A5010046486 @default.
• W2617007913 creator A5010938832 @default.
• W2617007913 creator A5024203424 @default.
• W2617007913 creator A5049524331 @default.
• W2617007913 creator A5058900172 @default.
• W2617007913 date "2017-05-23" @default.
• W2617007913 modified "2023-10-17" @default.
• W2617007913 title "Unravelling the biology of SCLC: implications for therapy" @default.
• W2617007913 cites W1504303645 @default.
• W2617007913 cites W1539969696 @default.
• W2617007913 cites W1554896841 @default.
• W2617007913 cites W1597178018 @default.
• W2617007913 cites W1628408467 @default.
• W2617007913 cites W1757407923 @default.
• W2617007913 cites W1762727355 @default.
• W2617007913 cites W1764416868 @default.
• W2617007913 cites W1778117100 @default.
• W2617007913 cites W1822869875 @default.
• W2617007913 cites W1862370067 @default.
• W2617007913 cites W1903523058 @default.
• W2617007913 cites W1919288105 @default.
• W2617007913 cites W1929286903 @default.
• W2617007913 cites W1934768104 @default.
• W2617007913 cites W1953598751 @default.
• W2617007913 cites W1965734230 @default.
• W2617007913 cites W1971563492 @default.
• W2617007913 cites W1973268287 @default.
• W2617007913 cites W1974217940 @default.
• W2617007913 cites W1976626368 @default.
• W2617007913 cites W1978286483 @default.
• W2617007913 cites W1979840121 @default.
• W2617007913 cites W1979932133 @default.
• W2617007913 cites W1982957001 @default.
• W2617007913 cites W1991494214 @default.
• W2617007913 cites W1995643652 @default.
• W2617007913 cites W1996506613 @default.
• W2617007913 cites W1996961433 @default.
• W2617007913 cites W2004630197 @default.
• W2617007913 cites W2004846981 @default.
• W2617007913 cites W2005458257 @default.
• W2617007913 cites W2006454684 @default.
• W2617007913 cites W2009007206 @default.
• W2617007913 cites W2018754160 @default.
• W2617007913 cites W2020966893 @default.
• W2617007913 cites W2023171799 @default.
• W2617007913 cites W2026809196 @default.
• W2617007913 cites W2028495676 @default.
• W2617007913 cites W2035263093 @default.
• W2617007913 cites W2035398180 @default.
• W2617007913 cites W2038143768 @default.
• W2617007913 cites W2041686632 @default.
• W2617007913 cites W2042134072 @default.
• W2617007913 cites W2043398720 @default.
• W2617007913 cites W2048671791 @default.
• W2617007913 cites W2049553585 @default.
• W2617007913 cites W2055175265 @default.
• W2617007913 cites W2058933379 @default.
• W2617007913 cites W2060070314 @default.
• W2617007913 cites W2060608189 @default.
• W2617007913 cites W2066772704 @default.
• W2617007913 cites W2068506054 @default.
• W2617007913 cites W2072039942 @default.
• W2617007913 cites W2073683299 @default.
• W2617007913 cites W2076887412 @default.
• W2617007913 cites W2078563859 @default.
• W2617007913 cites W2083352151 @default.
• W2617007913 cites W2086038769 @default.
• W2617007913 cites W2088766047 @default.
• W2617007913 cites W2089171902 @default.
• W2617007913 cites W2090074847 @default.
• W2617007913 cites W2091540336 @default.
• W2617007913 cites W2091588762 @default.
• W2617007913 cites W2094854433 @default.
• W2617007913 cites W2095475448 @default.
• W2617007913 cites W2096293110 @default.
• W2617007913 cites W2097597328 @default.
• W2617007913 cites W2097957857 @default.
• W2617007913 cites W2098161852 @default.
• W2617007913 cites W2100158834 @default.
• W2617007913 cites W2100419317 @default.
• W2617007913 cites W2101156795 @default.
• W2617007913 cites W2105241306 @default.
• W2617007913 cites W2106057638 @default.
• W2617007913 cites W2106985615 @default.
• W2617007913 cites W2107944850 @default.
• W2617007913 cites W2108927999 @default.
• W2617007913 cites W2109664345 @default.
• W2617007913 cites W2110017381 @default.
• W2617007913 cites W2112601576 @default.
• W2617007913 cites W2118444666 @default.
• W2617007913 cites W2121155221 @default.
• W2617007913 cites W2123767004 @default.
• W2617007913 cites W2125065061 @default.
• W2617007913 cites W2125568481 @default.
• W2617007913 cites W2130029734 @default.
• W2617007913 cites W2131664752 @default.

• next